BMJ Restoring Study 329 | Setting the Record Straight - Study finds Paxil not effective, caused serious side effects, including hostility, insomnia, and akathisia, significant dependence, 13 adodolescents became

  • The Saga Of Study 329 - A Chronology | Restoring Study 329 - Selective serotonin re-uptake inhibitors (SSRI) antidepressants burst on to the scene in 1988 with the introduction of fluoxetine/Prozac, hailed as a wonder
  • Correspondence With GSK | Restoring Study 329 - 2013-06-13 - Publication of RIAT Declaration Editorial |Full article | Print edition 2013-04-26 — Dr. Jureidini writes to GSK CEO Sir Andrew Witty.
  • The Data | Restoring Study 329 - In 2004 as part of the resolution of a fraud action taken by New York State, GlaxoSmithKline agreed to post the data from all their studies on the Company
  • Peer Reviews Keller et. al. | Restoring Study 329 - The Healthy Skepticism Web Site has many documents relating to the original Paxil Study 329: Paroxetine vs Imipramine vs Placebo in Adolescents. Here are the
  • Responses - BMJ | Restoring Study 329 - The following are excerpts from the BMJ Response Pages with the 329 Team responses. Some of the responses are expanded here. 18 September 2015 - Kim
  • Responses Keller et. al. | Restoring Study 329 - The Letter below from Marty Keller and colleagues was sent to many media outlets, to retraction watch, and to professional organizations on Wednesday. Paul
  • Attempts to Get Study 329 Retracted | Restoring Study 329 - Beginning soon after its 2001 publication, a number of journalists and researchers spotted the anomalies in Study 329’s data classification and interpretation
  • Restoring Study 329: The Path To Publication | Restoring Study 329 -   BMJ Publishing Mandate "The BMJ’s mission is to lead the debate on health, and to engage, inform, and stimulate doctors, researchers and other
  • Media | Restoring Study 329 - Media Contact See Study 329 Team for further individual contact details, or fill in the form below.  
  • BMJ Press Release and Materials | Restoring Study 329 - Reanalysis of antidepressant trial finds popular drug ineffective and unsafe for adolescents BMJ Press Release: 16 September 2015 Results contradict original
  • Questions & Answers | Restoring Study 329 - Q. What is paroxetine prescribed for, and what are its other names? A. Paroxetine is prescribed for depression, anxiety, panic attacks, post-traumatic stress
  • Videos | Restoring Study 329 - BBC Panorama broadcast ‘Secrets of Seroxat” (October 2002). Click here for transcript. BBC Panorama broadcast ‘Emails from the Edge’ (May 2003). Click here
  • Restoring Study 329 Team | Restoring Study 329 - Joanna Le Noury, PhD School of Medical Sciences, Bangor University (Bangor, Wales) RIAT role: Lead author on Restoring Study 329; data collection and
  • What Can I Do? | Restoring Study 329 - Journalist | Patient | Doctor | Concerned Citizen | Researcher Bad science affects us all. For those of us who have lost loved ones because of medical lies,
  • Study 329 Continuation Phase | Restoring Study 329 - September 21, 2016 — Study 329 had an 8-week acute phase and a further 24 week continuation phase. After 8 weeks the participants had an option to enter a
  • BMJ Publishes Study Revealing How Flawed Drug Research Fails a Trusting Public | Restoring Study 329 - Band of Intrepid Researchers "Sets the Record Straight" on Ghostwritten Study Toronto (September 16, 2015) — Today the BMJ published Restoring Study 329,* a

    Country:, North America, US

    City: -97.822 , United States

  • hscarfo - Informative, helpful and educational.

    Provides extensive travel hints, tour suggestions and highlights & background for all the key sites. Linked with the Steves audio book, this is a must read for anyone travelling to Rome or to other cities in Europe. Includes hotel and restaurant information, walking tours and guided tours for all the main sites. A complete list of contact information and phone numbers for various services is also provided.

  • Warren Dane - Outstanding performance

    I have used the 2003 version of Publisher for years. It did what I needed. However, the 2010 update I downloaded from is light years ahead in the variety of improvements in functionality, creative possibilities and reduction in RAM usage and reasonable in cost given it's improvements over earlier versions. I highly recommend it.